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Background: The co-occurance of multiple medical conditions has a negative impact on health related quality of
life (HRQoL) for patients with type 2 diabetes. These patients demand for intensified care programs. Participation in
a disease management program (DMP) for type 2 diabetes has shown to counterbalance this effect. However, it
remains unclear which dimensions of HRQoL are influenced by the DMP. The aim of this study was to explore the
HRQoL dimensions of patients with type 2 diabetes in the German DMP and patients in routine care (RC).
Methods: This analysis is part of a comparative evaluation of the German DMP for patients with type 2 diabetes. A
questionnaire, including the HRQoL measure EQ-5D, was mailed to a random sample of 3,546 patients with type 2
diabetes (59.3% female). The EQ-5D dimensions were analyzed by grouping patients according to their
participation in the German DMP for diabetes into DMP and RC.
Results: Compared to patients in DMP, patients in RC reported more problems for the dimensions mobility (P <
0.05), self care (P < 0.05) and performing usual activities (P < 0.01). Depending on the number of other conditions,
remarkable differences for reporting “no problems” exist for patients with six or more comorbid conditions
regarding the dimensions mobility (RC = 8.7%, DMP = 32.3%), self care (RC = 43.5%, DMP = 64.5%), usual activities
(RC = 13.0%, DMP = 33.9%) and anxiety or depression (RC = 37.0%, DMP = 48.4%).
Conclusion: Patients participating in the German DMP for type 2 diabetes mellitus show significantly higher ratings of
their HRQoL in the dimensions mobility, self care and performing usual activities compared to patients in RC. This
difference can also be observed in patients with significant comorbidities. As these dimensions are known to be
essential for diabetes care, the German DMP may contribute to improved care even for comorbid diabetes patients.
Background
A special disease management program (DMP) for
patients with type 2 diabetes has been in place in Ger-
many since 2003. This primary care-based continuous
program is accessible for all patients with type 2 dia-
betes insured within the statutory health insurance.
Currently more than 3,200,000 patients with type 2 dia-
betes participate in the DMP. Important elements of
this approach like evidence-based clinical guidelines or
transfer between different levels of care are defined by a
national expert group. In contrast to vendor-supported
programs in the United States, general practitioners in
small- to medium-sized practices have an important role
in coordinating the care of enrolled patients. Previous
evaluations of this program show positive results regard-
ing quality of care and health-related quality of life [1-3].
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mous challenge in the German DMP for type 2 dia-
betes. Up to 90 percent of enrolled patients suffer from
one or more co-occuring medical conditions [4].
Comorbidity is demanding for both healthcare systems
and patients. It implies complex clinical management
and increasing health care costs [5-7] as well as
impaired health-related quality of life (HRQoL). It is
known that the presence of co-occuring medical condi-
tions has a negative impact on HRQoL for patients with
type 2 diabetes [8-13]. We could previously show that
the German DMP for type 2 diabetes may help to coun-
terbalance the negative effect of comorbidity on HRQoL
[14]. However, it remains unclear which dimensions of
HRQoL are influenced by DMP. Therefore the aim of
this analysis was to assess differences in the five dimen-
sions of a valid multi-dimensional instrument for
HRQoL (EQ-5D) between patients participating in the
German DMP for type 2 diabetes and patients in rou-
tine care (RC).
Methods
This analysis was performed as part of the ELSID study
(Evaluation of a Large-scale Implementation of Disease
management programs; 2005-2007). This observational
study aims to compare the care provided within the
DMP with routine care (RC). The study protocol was
approved by the ethics committee of the University of
Heidelberg [15].
All of the participants in this study were insured by 1
large statutory regional healthcare fund called the Allge-
meine Ortskrankenkasse (AOK), which covers about
40% of the German population. Patients were identified
from routine claims data of this healthcare fund. To be
included in the study, patients had to be older than age
50 years and be receiving a prescription for antidiabetic
medication (oral antidiabetic drugs or insulin) in the
first half-year of 2005. Patients in the DMP group had
to be enrolled in the program by December 31, 2005,
regardless of how long they had participated in the pro-
gram prior to that date. Patients in the non-DMP group
were not enrolled in the DMP before this appointed
date.
Overall n = 20,625 patients (59.2% female) were
included in the ELSID-study. The population for the
presented survey was a random sample of 3,546 patients
(59.3% female) from all study patients. In 2006, these
patients received questionnaires with a cover letter sent
by their health insurance provider. Details of the data
acquisition have already been published [16].
In this survey we used the EQ-5D, a validated generic
instrument for measuring HRQoL, which is available in
more than 50 languages. The self-report questionnaire
consists of a descriptive system, which defines health in
terms of five dimensions: mobility, self-care, usual activ-
ities, pain or discomfort, and anxiety or depression.
Each dimension is divided into three levels, indicating
no problem (1st level), some or moderate problems
(2nd level) and extreme problems (3rd level). The level
of problem, reported on each of the EQ-5D dimensions,
determines a unique health state [17,18]. Further investi-
gations have demonstrated the usefulness of EQ-5D in
identifying determinants of health states [19,20]. The
questionnaire also included questions on sociodemo-
graphic characteristics (age, gender, educational level,
marital status, and household income), self-reported
health information (weight, height, and smoking status)
and a list of chronic conditions in lay language (hyper-
tension, osteoarthrosis, cancer, previous stroke, coronary
heart disease, COPD, asthma, heart failure, and previous
heart attack).
The EQ-5D dimensions were analyzed by grouping
patients according to their participation in the German
DMP for diabetes into DMP and RC. To analyze differ-
ences between groups we compared the proportion of
reported problems (none, moderate and extreme) and
calculated chi-square tests for each dimension. To
describe differences depending on comorbidity we com-
pared the proportion of reporting “no problems” for
each dimension between patient groups with different
n u m b e r so fo t h e rc o n d i t i o n s( 0 ,1 ,2 ,3 ,4 ,5 ,6a n d
more). All analyses were conducted using SPSS (version
15.0).
Results
A total of 1,532 questionnaires were returned (response
rate: 42.2%). Valid data were available for 1,399 patients,
more precisely 865 patients in DMP (61,83%) and 534
(38,17%) patients in RC. 53.6% of these were female and
the mean age for the entire sample was 70.3 (±8.5)
years. Significant differences between the two groups
(DMP and RC) did not exist for the total sample but for
some subgroups (Table 1).
The EQ-5D was completed by 1,291 patients. The
analysis of EQ-5D dimensions showed significant differ-
ences for reporting problems in the dimensions mobility
(P < 0.05), self care (P < 0.05) and performing usual
activities (P < 0.01). For the dimensions pain or discom-
fort and anxiety or depression we found no significant
difference (Table 2). Depending on the number of co-
occuring conditions differences for reporting “no pro-
blems” could be observed particularly for patients with
six or more co-occuring conditions in the dimensions
mobility (RC = 8.7%, DMP = 32.3%), self care (RC =
43.5%, DMP = 64.5%), usual activities (RC = 13.0%,
DMP = 33.9%) and anxiety or depression (RC = 37.0%,
DMP = 48.4%) (Table 3). However, these observed dif-
ferences were not statistically significant.
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The analysis revealed differences between DMP and RC
patients for the HRQoL dimensions “mobility”, “self
care”,a n d“performing usual activities”. DMP patients
reported significantly less problems in these dimensions.
These differences could also be observed in patients
with significant comorbidities.
These results are in line with our previous findings
[14] and provide additional understanding of how the
German DMP for patients with type 2 diabetes mellitus
Table 1 Patient characteristics
Number of other chronic conditions
Sample no 1 2 3 4 5 6 ≤
DMP RC DMP RC DMP RC DMP RC DMP RC DMP RC DMP RC DMP RC
N 865 534 66 40 189 111 214 140 178 91 93 64 60 42 65 46
Age (mean) 70.2 70.5 72.4 68.6* 69.2 69.6 69.8 71.3 70,4 70,9 69.5 70.8 71.8 70.7 72.2 71.8
Age (SD) ±8.3 ±8.9 ±8.0 ±7.7 ±8.0 ±9.3 ±8.5 ±8.5 ±8,2 ±8,9 ±7.6 ±7.8 ±9.0 ±10.4 ±8.9 ±8.7
Female subjects (%) 53.8 53.4 53.0 55.0 55.6 47.7 57.9 58.9 51,7 59,3 47.3 50.0 56.7 40.5 44.6 56.5
Education ≤9 years (%) 70.8 72.3 76.7 81.1 75.9 75.5 75.0 79.6 74,7 85.7* 76.1 76.7 76.8 86.1 79.7 79.1
Living in partnership (%) 65.7 62.9 55.4 52.6 64.9 64.2 61.9 62.0 66,7 52.8* 63.7 63.5 52.6 61.9 64.1 51.1
BMI (mean) 30.3 30.3 29.1 30.3 29.4 30.2 30.5 29.3 30,7 30,4 31.3 30.1 31.0 33.2 30.2 31.4
BMI (SD) ±5.8 ±6.5 ±5.2 ±5.2 ±5.0 ±6.1 ±5.7 ±6.1 ±6,6 ±7,5 ±5.7 ±5.7 ±6.6 ±7.4 ±6.0 ±7.2
Hypertension (%) 71.3 72.1 ———— ———— 24.3 20.7 62.1 63.6 74,2 73,6 77.4 82.8 91.7 69.0 87.7 91.3
Osteoarthrosis (%) 57.2 56.7 ———— ———— 57.7 49.5 79.0 77.9 83,7 89,0 87.1 90.6 85.0 90.5* 89.2 95.7
Coronary heart (%) 20.9 20.4 ———— ———— 0.5 7.2* 7.0 7.1 24,2 17,6 50.5 42.2 51.7 40.5 67.7 67.4
Heart failure (%) 16.9 18.0 ———— ———— 3.7 2.7 9.3 5.7 17,4 13,2 32.3 32.8 48.3 50.0 44.6 67.4*
COPD (%) 9.9 10.9 ———— ———— 0.5 3.6* 4.2 3.6 10,7 9,9 25.8 25.0 13.3 16.7 38.5 37.0
Cancer (%) 7.6 9.0 ———— ———— 3.2 1.8 5.6 4.3 6,7 11,0 16.1 17.2 13.3 4.8 20.0 37.0
Previous heart attack (%) 7.1 8.2 ———— ———— 0.5 0.0 0.9 6.4* 8,4 8,8 18.3 10.9 11.7 19.0 29.2 26.1
Previous stroke (%) 6.0 6.6 ———— ———— 1.1 2.7 3.7 2.1 9,0 7,7 6.5 12.5 15.0 11.9 16.9 19.6
Asthma (%) 4.2 4.5 ———— ———— 0.0 0.9 1.4 1.4 7,3 2,2 4.3 4.7 11.7 26.2 13.8 10.9
* P < 0.05
Table 2 Analysis of EQ-5D dimensions (n = 1291)
Dimension Sample Problems p-value*
RC DMP level RC DMP
nn %%
mobility 482 809 no 51,3 54,6 0.041
some 47,6 45,2
extreme 1,0 0,1
self care 482 809 no 80,1 84,7 0.010
some 15,7 13,7
extreme 4,1 1,6
performing usual activities 482 809 no 56,3 59,5 0.006
some 35,0 36,2
extreme 8,7 4,3
pain/discomfort 482 809 no 19,0 19,4 0.088
some 65,6 69,5
extreme 15,3 11,1
anxiety/depressed 482 809 no 67,5 66,9 0.682
some 28,4 29,8
extreme 4,1 3,3
*chi-square test
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tions of descriptive studies do not allow any conclusion
on causal relationship. Nevertheless, the results give rise
to the question as to which elements of the German
DMP for type 2 diabetes could be contributing to the
differences between groups. Indeed, we know that
aspects like physical activities or social support can
improve HRQoL [21-23]. Even so, it is uncertain which
specific elements of DMP, such as structured care, regu-
lar follow ups or patient education programs, are
responsible for the fact that patients - especially those
with numerous other conditions - reported less
problems.
Physical activity is an essential component of diabetes
management [24]. Therefore, reporting less problems in
the HRQoL dimension “mobility” m a yi n d i c a t et h a ta
higher proportion of DMP patients would be able to be
physically active than RC patients. However, the actual
level of physical activity of both groups was not assessed
in this survey. “Self-care” as well as the ability to per-
form “usual activities” is seen to be crucial for indepen-
dent living and HRQoL. The observed differences may
therefore explain our previous results [14].
Our study is further limited by a moderate response
rate. This rate might have been higher if the question-
naires had been sent out by the university department
directly instead of the health fund. Due to a strict pro-
tection of data privacy we were not able to contact the
p a t i e n t sd i r e c t l y .A l s ow ed on o tk n o ww h e t h e ra n d
how motivation to participate in a DMP affects HRQoL.
Potential differences (age, gender, DMP status) between
responders and non-responders may also affect our
results. It should be considered that the age of patients
in our sample is substantially higher than usually seen
in diabetes studies.
Conclusions
Patients participating in the German DMP for type 2
diabetes mellitus show significantly higher ratings of
their HRQoL in the dimensions mobility, self care and
performing usual activities compared to patients in RC.
This difference can also be observed in patients with
significant comorbidities. As these dimensions are
known to be essential for diabetes care, the German
DMP may contribute to improved care even for comor-
bid diabetes patients.
Acknowledgements
This study is an investigator-initiated trial funded by the Federal Association
of Statutory Regional Health Funds (AOK Bundesverband). Under the
contract between the sponsor and the University of Heidelberg, full
responsibility for the scientific work, the management of data and analysis
and publication rests with the investigators. We are grateful to the regional
health funds AOK Sachsen-Anhalt and AOK Rheinland Pfalz for support in
sending out the study material to their policyholders and for the
preparation of claims data for sampling purposes.
Author details
1Department of General Practice and Health Services Research, University
Hospital of Heidelberg, Vosstrasse 2, D-69115 Heidelberg, Germany.
2Institute
of Medical Biometry and Informatics, University Hospital of Heidelberg, Im
Neuenheimer Feld 305, D-69120 Heidelberg, Germany.
Authors’ contributions
AM and JS initiated, designed and coordinated the study. DO and TF carried
out data-analysis and wrote the manuscript. CUK gave statistical advice. All
authors, particularly IN and EU, read earlier versions of the manuscript,
provided critical comments, and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 February 2011 Accepted: 2 August 2011
Published: 2 August 2011
References
1. Schäfer I, Küver C, Gedrose B, Hoffmann F, Ruß-Thiel B, Brose HP, van den
Busche H, Kaduszkiewicz H: The disease management program for type 2
diabetes in Germany enhances process quality of diabetes care - a
follow-up survey of patient’s experiences. BMC Health Service Research
2010, 10:55.
2. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A: German
diabetes disease management programs are appropriate for
restructuring care according to the chronic care model: an evaluation
with the patient assessment of chronic illness care instrument. Diabetes
Care 2008, 31:1150-1154.
3. Stock S, Drabik A, Büscher G, Graf C, Ullrich W, Gerber A, Lauterbach KW,
Lüngen M: German Diabetes Management Programs Improve Quality of
Care And Curb Costs. Health Aff 2010 29:2197-2205.
Table 3 No problems reported by number of other chronic conditions (n = 1291)
number of other conditions sample mobility self care usual activities pain/discomfort anxiety/depression
RC DMP RC DMP RC DMP RC DMP RC DMP RC DMP
nn%%%% % % % % % %
0 32 58 87,5 75,9 90,6 86,2 71,9 86,2 40,6 55,2 87,5 82,8
1 99 179 75,8 74,9 91,9 93,9 77,8 82,1 37,4 36,9 80,8 76,0
2 129 203 56,2 51,7 83,1 85,2 60,8 59,1 20,8 14,8 70,8 66,5
3 82 163 50,0 53,4 79,3 85,9 58,5 52,8 11,0 9,8 63,4 62,0
4 58 86 29,3 38,4 81,0 81,4 46,6 47,7 5,2 9,3 65,5 65,1
5 36 58 27,8 32,8 75,0 75,9 33,3 27,6 5,6 3,4 52,8 60,3
≥6 46 62 8,7 32,3 43,5 64,5 13,0 33,9 2,2 4,8 37,0 48,4
Ose et al. BMC Health Services Research 2011, 11:179
http://www.biomedcentral.com/1472-6963/11/179
Page 4 of 54. Altenhofen L, Blaschy S, Hagen B, Haß W, Kretschmann J: Qualitätsbericht
2006. [Disease Management Programme in Nordrhein]. Nordrheinische
Gemeinsame Einrichtung; 2008.
5. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M: Defining
Comorbidity: Implications for Understanding Health and Health Services.
Ann Fam Med 2009, 7:357-363.
6. Piette JD, Kerr EA: The Impact of Comorbid Chronic Conditions on
Diabetes Care. Diabetes Care 2006, 29:725-731.
7. Halanych JH, Safford MM, Keys WC, Person SD, Shikany JM, Kim YI,
Centor RM, Allison JJ: Burden of comorbid medical conditions and quality
of diabetes care. Diabetes Care 2007, 30:2999-3004.
8. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L,
Blais MA, Meigs JB: Correlates of health related quality of life in type 2
diabetes. Diabetologia 2006, 49:1489-1497.
9. UK. Prospective Diabetes Study Group: Quality of Life in Type 2 Diabetic
Patients Is Affected by Complications But Not by Intensive Policies to
Improve Blood Glucose or Blood Pressure Control (UKPDS 37). Diabetes
Care 1999, 22:1125-1136.
10. Maddigan SL, Feeny DH, Johnson JA: Health related quality of life deficits
associated with diabetes and comorbidities in a Canadian National
Population Health Survey. Qual Life Res 2005, 14:1311-1320.
11. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM,
Kaplan RM, Herman WH: Valuing Health-Related Quality of Life in
Diabetes. Diabetes Care 2002, 25:2238-2243.
12. Wee HL, Chueng YB, Li SC, Fong KY, Thumboo J: The impact of diabetes
mellitus and other chronic medical conditions on health-related Quality
of Life: Is the whole greater than the sum of its parts? Health Qual Life
Outcomes 2005, 3:2.
13. Koopmanschap M: Coping with Type II diabetes: the patient’s
perspective. Diabetologie 2002, 45:S18-S22.
14. Ose D, Wensing M, Szecsenyi J, Joos S, Hermann K, Miksch A: Impact of
Primary Care-Based Disease Management on the Health-Related Quality
of Life in Patients With Type 2 Diabetes Comorbidity. Diabetes Care 2009,
32:1594-1596.
15. Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J,
Kaufmann-Kolle P, Szecsenyi J: ELSID-Diabetes study-evaluation of a large
scale implementation of disease management programmes for patients
with type 2 diabetes. In BMC Public Health. Volume 5. Rationale, design and
conduct - a study protocol [ISRCTN08471887]; 2005:99.
16. Miksch A, Herman K, Rölz A, Joos S, Szecsenyi J, Ose D, Rosemann T:
Additional impact of concomitant hypertension and osteoarthritis on
quality of life among patients with type 2 diabetes in primary care in
Germany - a cross-sectional survey. Health Qual Life Outcomes 2009, 7:19.
17. EuroQol Group: EuroQol - e new facility for the measurement of health-
related quality of life. Health Policy 1990, 16:199-208.
18. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J,
Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M,
Sintonen H, Tsuchiya A, de Charro F: A single European currency for EQ-
5D health states. Results from a six-country study. Eur J Health Econom
2003, 4:222-231.
19. Barton GR, Sach TH, Doherty M, Avery AJ, Jenkinson C, Muir KR: An
assessment of the discriminative ability of the EQ-5D index, SF-6D, and
EQ VAS, using sociodemographic factors and clinical conditions. Eur J
Health Econ 2008, 9:237-249.
20. Grandy S, Fox KM: EQ-5D visual analog scale and utility index values in
individuals with diabetes and risk for diabetes. Findings from the Study
to Help Improve Early evaluation and management of risk factors
Leading to Diabetes (SHIELD). Health Qual Life Outcomes 2008, 6:18-25.
21. Chyun DA, Melkus GD, Katten DM, Price WJ, Davey JA, Grey N, Heller G,
Wackers FJ: The association of psychological factors, physical activities,
neuropathy, and quality of live in type 2 diabetes. Biol Res Nurs 2008,
7:279-288.
22. Acree LS, Longfors J, Fjeldstad AS, Fjeldstad C, Schank B, Nickel KJ,
Montgomery PS, Gardner AW: Physical activity is related to quality in
older adults. Health Qual Life Outcomes 2006, 4:37.
23. Göz F, Kraoz S, Goz M, Ekiz S, Cetin I: Effects of the diabetic perceived
support on their quality-of-life. J Clin Nurs 2007, 16:1353-1360.
24. Sigal JF, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical Activity/
Exercise and Type 2 Diabetes. Diabetes Care 2004, 10:2518-2539.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6963/11/179/prepub
doi:10.1186/1472-6963-11-179
Cite this article as: Ose et al.: Health related quality of life and
comorbidity. A descriptive analysis comparing EQ-5D dimensions of
patients in the German disease management program for type 2
diabetes and patients in routine care. BMC Health Services Research 2011
11:179.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ose et al. BMC Health Services Research 2011, 11:179
http://www.biomedcentral.com/1472-6963/11/179
Page 5 of 5